Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.

Elia SechiEslam ShoshaJonathan P WilliamsSean J PittockBrian G WeinshenkerB Mark KeeganNicholas L ZalewskiAlfonso Sebastian Lopez-ChiribogaJiraporn JitprapaikulsanEoin P Flanagan

Published in: Neurology (2019)

The availability of AQP4-IgG and MOG-IgG modestly reduced ITM incidence and prevalence, which remained higher than previously reported in this predominantly white population. Incorporation of these biomarkers into future revisions of TM diagnostic criteria should be considered.

Keyphrases

risk factors
small molecule
current status
high throughput
african american
single cell